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Abstract
The medial hypothalamus is part of a neurobiological substrate controlling defensive behavior. It has been shown that a hypo-
thalamic nucleus, the dorsomedial hypothalamus (DMH), is involved in the regulation of escape, a defensive behavior related 
to panic attacks. The role played by the DMH in the organization of conditioned fear responses, however, is less clear. In the 
present study, we investigated the effects of reversible inactivation of the DMH with the GABAA agonist muscimol on inhibitory 
avoidance acquisition and escape expression by male Wistar rats (approximately 280 g in weight) tested in the elevated T-maze 
(ETM). In the ETM, inhibitory avoidance, a conditioned defensive response, has been associated with generalized anxiety dis-
order. Results showed that intra-DMH administration of the GABAA receptor agonist muscimol inhibited escape performance, 
suggesting an antipanic-like effect (P < 0.05), without changing inhibitory avoidance acquisition. Although a higher dose of 
muscimol (1.0 nmol/0.2 µL; N = 7) also altered locomotor activity in an open field when compared to control animals (0.2 µL 
saline; N = 13) (P < 0.05), the lower dose (0.5 nmol/0.2 µL; N = 12) of muscimol did not cause any motor impairment. These 
data corroborate previous evidence suggesting that the DMH is specifically involved in the modulation of escape. Dysfunction 
of this regulatory mechanism may be relevant in the genesis/maintenance of panic disorder.
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The medial hypothalamus has been implicated in the 
regulation of a series of different behavioral and physi-
ological functions, such as food ingestion and metabolism, 
reproduction, and defense (1). This region contains a 
number of anatomically and functionally well-defined cell 
groups (1), such as the dorsomedial hypothalamus (DMH), 
the anterior hypothalamic nucleus, the dorsomedial part of 
the ventromedial hypothalamus (VMHdm) and the dorsal 
premammillary nucleus. These nuclei are interconnected 
and, regarding defensive reactions, seem to be especially 
involved in the integration of innate responses to environ-
mental threats (1-4). In fact, it has been shown that the 
electrical stimulation of this region induces unconditioned 
escape behavior and autonomic arousal resembling those 
presented by animals when facing natural threats (5,6). 
Intramedial hypothalamus administration of glutamate 
agonists (2,7) and of GABA antagonists (3,8,9) also evokes 
a similar defense pattern. This last observation suggests 
that GABAergic mechanisms exert a tonic inhibition on this 
neural substrate of defense.
It is interesting to point out that, based on the etho-
pharmacological analysis of the rodent defensive repertoire, 
escape behavior has been associated with fear (10,11), and 
dysfunction of the brain circuitry controlling this behavior 
has been related to panic disorder (10,12). Thus, altogether, 
previous studies suggest that the medial hypothalamus 
plays a relevant role not only in the regulation of escape 
behavior but also in the pathophysiology of panic disorder 
(3,13). The role of the region in the regulation of condi-
tioned defense reactions, however, is less clear. Given 
the importance of the medial hypothalamus in defense, a 
full understanding of the extent to which this region also 
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integrates conditioned fear is of relevance. 
In the present study, we compared the relationship of a 
specific hypothalamic nucleus, the DMH, with escape and 
conditioned defense reactions in the same animal. For this 
purpose, male Wistar rats were injected intra-DMH with 
the GABAA receptor agonist muscimol and tested in the 
elevated T-maze (ETM). Muscimol was used to reversibly 
inactivate the nucleus. In the ETM, escape behavior is 
induced by an ethologically relevant threatening stimulus, 
i.e., the exposure of rats to an open and elevated space 
(14-16). Besides escape, the model also allows the mea-
surement of inhibitory avoidance (14), a conditioned defense 
response. The pharmacological validation of the ETM has 
shown that compounds representative of three classes of 
anxiolytics - namely the agonist of benzodiazepine receptors 
diazepam, the serotonin (5-HT) 1A agonist buspirone, and 
the nonselective 5-HT2 antagonist ritanserin - selectively 
impair inhibitory avoidance while leaving one-way escape 
unchanged (14). These results are compatible with the view 
that inhibitory avoidance relates to generalized anxiety. In 
contrast, the escape task is impaired by chronic, but not 
acute administration of imipramine (15), clomipramine and 
fluoxetine (16), drugs that are used to treat panic. As a 
result, one-way escape in the ETM has been used as an 
animal model of panic disorder.
In order to avoid confounding results due to drug effects 
on locomotor activity, after tests in the ETM, animals were 
also evaluated in an open field. 
Subjects and Methods
Subjects
Twenty-nine male Wistar rats (Federal University of São 
Paulo, CEDEME, Brazil) weighing approximately 280 g at 
the beginning of the experiment were housed in groups of 
5-6 per cage. After surgery, animals were housed in pairs 
in Plexiglas-walled cages until testing. Room tempera-
ture was controlled (22 ± 1°C) and a light-dark cycle was 
maintained on a 12-h on-off cycle (lights on from 7:00 to 
19:00 h). Food and water were available throughout the 
experiments. The study was performed in compliance with 
the recommendations of the SBNeC (Brazilian Society of 
Neuroscience and Behavior), which are based on the US 
National Institutes of Health Guide for Care and Use of 
Laboratory Animals.
Apparatus
The elevated T-maze was made of wood and had 3 arms 
of equal dimensions (50 x 12 cm). One of the arms was 
enclosed by 40-cm high walls and was oriented perpen-
dicularly to two opposite open arms. The whole apparatus 
was elevated 50 cm above the floor. To avoid falls, the open 
arms were surrounded by a 1-cm high Plexiglas rim. 
The open field test was performed in a wooden square 
arena (60 x 60 cm) with 30-cm high walls. Luminosity at 
the level of the maze arms or the open field center was 
60 lux.
Drugs
Muscimol (0.5 and 1.0 nmol; Sigma, USA) was dissolved 
in sterile saline. Control animals received sterile saline. Drug 
and saline were administered in a volume of 0.2 µL.
Surgery
Rats were anesthetized with an intraperitoneal (ip) 
injection of ketamine hydrochloride (80 mg/kg; Agribrands, 
Brazil) and xylazine (10 mg/kg; Agribrands) and fixed to a 
stereotaxic frame (Insight, Brazil). Before the implant of a 
stainless steel guide cannula into the DMH, the animals 
received local anesthesia with 2% lidocaine with a vaso-
constrictor (Harvey, Brazil). The cannula (0.6-mm outer 
diameter and 0.4-mm inner diameter) was inserted into 
the right side of the brain through a hole drilled in the skull 
above the hypothalamic nucleus, following the coordinates 
from the atlas of Paxinos and Watson (17): AP = -3.1 mm 
from Bregma, ML = +0.6 mm, and DV = -7.2. Guide can-
nulas were attached by means of acrylic resin and a stain-
less steel screw. Stylets with the same length as the guide 
cannula were introduced inside them to avoid obstruction. 
To prevent infections, at the end of surgery, all animals 
were injected intramuscularly with 0.2 mL of a pentabiotic 
preparation (Pentabiótico Veterinário Pequeno Porte; Forte 
Dodge, Brazil) and with the anti-inflammatory Banamine (1 
mL/kg, sc; Fort Dodge).
Microinjections
For drug injection, needles (0.3-mm outer diameter) 
were introduced through the guide cannula until their tip was 
2 mm below the cannula end. Muscimol and saline were 
injected over a period of 120 s using 5-µL microsyringes 
(Hamilton 701-RN, USA) attached to a microinfusion pump 
(Insight). The displacement of an air bubble inside the 
polyethylene catheter connecting the syringe needle to the 
intracerebral needle was used to monitor the microinjec-
tion. The intracerebral needles were removed 60 s after 
the end of injection. 
Procedure
Five days after surgery, the animals were exposed to 
one of the open arms of the ETM for 30 min as described 
by Sena et al. (18). It has been shown that pre-exposure 
renders the escape task more sensitive to the effects of 
antipanic drugs because it shortens the latencies of with-
drawal from the open arm during the test (18). On the next 
day, rats were injected (0.2 µL, 2 min) with muscimol (0.5 
and 1.0 nmol) or saline. Ten minutes later, ETM-inhibitory 
avoidance was measured by recording the time taken by the 
rats to withdraw from the enclosed arm of the maze in three 
consecutive trials at 30-s intervals (baseline, avoidance 1 
and 2). Following avoidance training (30 s), each animal 
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was placed at the end of the same open arm as used in 
the pre-exposure session and the time taken to leave this 
arm was recorded in three consecutive trials (escape 1 to 
3), again with 30-s inter-trial intervals. Immediately after the 
tests in the ETM, animals were placed in the center of the 
open field and allowed to freely explore for 5 min.
Histology
After the experiments, animals were sacrificed under 
deep urethane anesthesia. Their brains were perfused 
through the heart with saline followed by 10% formalin, 
before being removed and fixed in 10% formalin. Frozen 
sections of 55 µm were cut with a microtome (Leica, Ger-
many) in order to locate the site of drug injections (17). 
Statistical analysis
Avoidance and escape data were submitted to repeated 
measures analysis of variance (ANOVA), with treatment as 
the independent factor and trials (baseline, avoidance 1 and 
2 or escape 1, 2, and 3 latencies) as the dependent factor. 
When appropriate, group comparisons were made by the 
Tukey test. Locomotor activity data in the open field were 
analyzed by one-way ANOVA followed by the Tukey test. A 
value of P ≤ 0.05 was considered to be significant.
Results
Figure 1 (upper panel, left side) shows intra-DMH injec-
tion of muscimol on ETM-inhibitory avoidance acquisition. 
Figure 1. Effects (mean + SEM) of intra-dorsomedial hypothalamus (DMH) muscimol (0.5 and 1.0 nmol/0.2 µL; left side) on inhibitory 
avoidance (upper panel) and escape (lower panel) latencies measured in the elevated T-maze (left side). The effects of injections 
outside the nucleus are represented on the right side of the figure. The latencies to leave the enclosed arm (baseline, avoidance 1 
and avoidance 2) or one of the open arms (escape 1-3) were measured sequentially at 30-s intervals beginning 10 min after intra-
DMH injection of either drug or saline. N = 13 (saline), 12 (0.5 nmol) and 7 (1.0 nmol). *P < 0.05 compared to control in the same trial 
(ANOVA followed by the Tukey post hoc test).
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Repeated measures ANOVA showed a significant effect 
of trials [F(2,58) = 6.60; P = 0.003], but not of treatment 
[F(2,29) = 0.482; P = 0.623] or of treatment by trial interaction 
[F(4,58) = 0.397; P = 0.810]. In a similar way, injections of 
muscimol outside the DMH did not alter inhibitory avoidance 
in the ETM (Figure 1, upper panel, right side).
Figure 1 (lower panel, left side) shows intra-DMH in-
jection of muscimol on ETM escape. Repeated measures 
ANOVA showed a significant effect of trials [F(2,58) = 4.659; 
P = 0.013], treatment [F(2,29) = 5.379; P = 0.010] and 
treatment by trial interaction [F(4,58) = 4.855; P = 0.002]. 
The Tukey post hoc test showed that animals treated with 
0.5 nmol muscimol were significantly different from the 
control group in escape 2 and that animals treated with 1.0 
nmol muscimol were significantly different from the control 
group in escape 3 (P < 0.05). On the other hand, escape 
measurements were not altered by injections of muscimol 
outside the DMH (Figure 1, lower panel, right side). 
As shown in Figure 2 (left side), both the number of 
crossings and the number of rearings in the open field 
were significantly altered by the highest dose of muscimol 
(1.0 nmol) administered intra-DMH (P < 0.05). In contrast, 
neither the number of crossings nor the number of rearings 
in the open field were significantly altered by injections of 
muscimol outside the DMH (Figure 2, right side).
Discussion
The present results showed that the temporary inacti-
vation of the DMH by local injection of the GABAA agonist 
muscimol selectively impaired escape behavior in the ETM, 
a panicolytic effect. Although the highest dose of muscimol 
administered (1.0 nmol) also altered locomotor activity in 
the open field, the lower dose (0.5 nmol) did not cause 
any motor impairment. The decrease in locomotor activity 
was probably also responsible for the increase in baseline 
latencies observed after intra-DMH treatment with 1 nmol 
muscimol (Figure 1, upper panel, left side). In fact, baseline 
latency in the ETM is used as an index of motor activity 
and not of fear/anxiety (15). Furthermore, the analysis of 
animals with cannula placement outside the DMH did not 
show any significant results in ETM avoidance or escape 
measurements (Figure 1, right side), confirming that the 
significant results observed were in fact due to the revers-
ible inactivation of this hypothalamic nucleus. 
The effect of DMH inactivation on escape expression 
corroborates previous reports. In fact, it has been shown that 
escape is evoked after chemical stimulation of the medial 
hypothalamus with glutamate agonists (2,7). Similar obser-
vations have also been reported after local administration 
of GABA antagonists into the region (8-9). Furthermore, 
the injection of GABA/BZD agonists into the medial hypo-
thalamus seems to modulate the aversive consequences 
of the electrical or chemical stimulation, raising the aversive 
threshold necessary to induce escape responses (2,9). 
In the present study, the relationship between a specific 
nucleus of the medial hypothalamus, the DMH, and escape 
was demonstrable when this behavior was evoked by an 
ethologically relevant threatening stimulus, i.e., exposure 
to an open and elevated space. As previously mentioned, 
dysfunction of the brain circuitry controlling escape has 
been related to panic disorder (10,12). In this regard, it is 
worth mentioning that impairment of the GABAergic func-
tion of the DMH by chronic inhibition of the GABA synthesis 
inhibitor L-allylglycine (L-AG) induced robust panic-like 
responses in rats (3) that were prevented by administration 
of the benzodiazepine alprazolam and LY354740, a potent 
group II metabotropic glutamate receptor agonist (3). Thus, 
it seems that the DMH is, in fact, an important neurobiologi-
cal substrate of the medial hypothalamic zone implicated 
in the pathophysiology of panic disorder.
On the other hand, intra-DMH administration of mus-
Figure 2. Effects (mean + SEM) of intra-dorsomedial hypothalamus (DMH) muscimol (0.5 and 1.0 nmol/0.2 µL) on the total number 
of crossings and rearings in an open field. The effects of injections outside the nucleus are represented on the right side of the figure. 
Measurements were made immediately after tests in the elevated T-maze. *P < 0.05 compared to control (ANOVA followed by the 
Tukey post hoc test). For additional information, see Figure 1.
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cimol did not change ETM avoidance measurements, a 
conditioned anxiety response. This effect corroborates what 
has been shown by Santos and co-workers (4) with the fear-
potentiated startle response to light, also a conditioned fear 
reaction. In this particular study (4), both muscimol and the 
glutamic acid decarboxylase inhibitor semicarbazide were 
without effect when administered intra-DMH.
The results observed with the DMH are very similar 
to those obtained with another neuroanatomic region 
implicated in defense, i.e., the dorsal periaqueductal gray 
(dPAG). When administered intra-dPAG, muscimol also 
impaired escape, without altering ETM-inhibitory avoid-
ance (19). In fact, the similarities of the role played by the 
medial hypothalamus and the dPAG in the modulation of 
defense were previously pointed out by Schmitt et al. (8), 
who showed that both intra-dPAG and intramedial hypo-
thalamus administrations of SR 95103, a GABA-A receptor 
antagonist, produced a dose-dependent behavioral activa-
tion together with jumps. In contrast, the present results do 
not agree with those observed with another hypothalamic 
nucleus, the VMHdm (20). Previous observations have 
shown that muscimol inhibits both ETM-inhibitory avoidance 
and escape when administered intra-VMHdm. Thus, on 
the basis of these results, it seems possible that different 
medial hypothalamic nuclei play distinct roles in the modula-
tion of fear/anxiety responses. While most caudal nuclei of 
the medial hypothalamus seem to modulate panic-related 
responses, such as escape, more rostral nuclei, such as 
the VMHdm, also mediate conditioned fear. Nevertheless, 
further work needs to be done to understand how these 
systems are possibly interrelated. 
In conclusion, the results of the present study suggest 
that inactivation of the DMH by muscimol selectively alters 
escape, a defensive response related to panic. Dysfunction 
of this regulatory mechanism may be of relevance in the 
genesis/maintenance of panic disorder.
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